CNS-expressed cathepsin D prevents lymphopenia in a murine model of congenital neuronal ceroid lipofuscinosis

American Journal of Pathology

Volumn 177, Issue 1, 2010, Pages 271-279

  Shevtsova, Zinayida ^a   Garrido, Manuel ^a   Weishaupt, Jochen ^a   Saftig, Paul ^c   Bähr, Mathias ^a   Lühder, Fred ^b   Kügler, Sebastian ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

^c UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CATHEPSIN D;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN NERVE CELL; CELL ACTIVATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; ENZYME ACTIVITY; HOMEOSTASIS; IMMUNE SYSTEM; IMMUNOMODULATION; LYMPH VESSEL; LYMPHOCYTOPENIA; MICROGLIA; MOUSE; NEURONAL CEROID LIPOFUSCINOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION;

EID: 77954615671     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.091267     Document Type: Article

References (36)

1. Saftig P, Hetman M, Schmahl W, Weber K, Heine L, Mossmann H, Koster A, Hess B, Evers M, von Figura K: Mice deficient for the lysosomal proteinase cathepsin D exhibit progressive atrophy of the intestinal mucosa and profound destruction of lymphoid cells. EMBO J 1995, 14:3599-3608
2. Baechle D, Flad T, Cansier A, Steffen H, Schittek B, Tolson J, Herrmann T, Dihazi H, Beck A, Mueller GA, Mueller M, Stevanovic S, Garbe C, Mueller CA, and Kalbacher H: Cathepsin D is present in human eccrine sweat and involved in the postsecretory processing of the antimicrobial peptide DCD-1L. J Biol Chem 2006, 281:5406-5415
3. Saftig P, Peters C, von Figura K, Craessaerts K, Van Leuven F, De Strooper B: Amyloidogenic processing of human amyloid precursor protein in hippocampal neurons devoid of cathepsin D. J Biol Chem 1996, 271:27241-27244 (Pubitemid 26367274)
4. Lkhider M, Castino R, Bouguyon E, Isidoro C, Ollivier-Bousquet M: Cathepsin D: released by lactating rat mammary epithelial cells is involved in prolactin cleavage under physiological conditions. J Cell Sci 2004, 117:5155-5164 (Pubitemid 39517530)
5. Hilfiker-Kleiner D, Kaminski K, Podewski E, Bonda T, Schaefer A, Sliwa K, Forster O, Quint A, Landmesser U, Doerries C, Luchtefeld M, Poli V, Schneider MD, Balligand JL, Desjardins F, Ansari A, Struman I, Nguyen NQ, Zschemisch NH, Klein G, Heusch G, Schulz R, Hilfiker A, Drexler H: A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell 2007, 128:589-600
6. Heinrich M, Neumeyer J, Jakob M, Hallas C, Tchikov V, Winoto-Morbach S, Wickel M, Schneider-Brachert W, Trauzold A, Hethke A, Schutze S: Cathepsin D links TNF-induced acid sphingomyelinase to Bid-mediated caspase-9 and -3 activation. Cell Death Differ 2004, 11:550-563
7. Benes P, Vetvicka V, Fusek M: Cathepsin D-many functions of one aspartic protease. Crit Rev Oncol Hematol 2008, 68:12-28
8. Moss CX, Villadangos JA, Watts C: Destructive potential of the aspartyl protease cathepsin D in MHC class II-restricted antigen processing. Eur J Immunol 2005, 35:3442-3451
9. Deussing J, Roth W, Saftig P, Peters C, Ploegh HL, Villadangos JA: Cathepsins B and D: are dispensable for major histocompatibility complex class II-mediated antigen presentation. Proc Natl Acad Sci USA 1998, 95:4516-4521
10. Fusek M and Vetvicka V: Mitogenic function of human procathepsin D: the role of the propeptide. Biochem J 1994, 303:775-780
11. Benes P, Vashishta A, Saraswat-Ohri S, Fusek M, Pospisilova S, Tichy B, Vetvicka V: Effect of procathepsin D activation peptide on gene expression of breast cancer cells. Cancer Lett 2006, 239:46-54 (Pubitemid 43946580)
12. Siintola E, Partanen S, Stromme P, Haapanen A, Haltia M, Maehlen J, Lehesjoki AE, Tyynela J: Cathepsin D deficiency underlies congenital human neuronal ceroid-lipofuscinosis. Brain 2006, 129:1438-1445
13. Steinfeld R, Reinhardt K, Schreiber K, Hillebrand M, Kraetzner R, Bruck W, Saftig P, Gartner J: Cathepsin D deficiency is associated with a human neurodegenerative disorder. Am J Hum Genet 2006, 78:988-998
14. Tyynela J, Sohar I, Sleat DE, Gin RM, Donnelly RJ, Baumann M, Haltia M, Lobel P: A mutation in the ovine cathepsin D gene causes a congenital lysosomal storage disease with profound neurodegeneration. EMBO J 2000, 19:2786-2792
15. Fritchie K, Siintola E, Armao D, Lehesjoki AE, Marino T, Powell C, Tennison M, Booker JM, Koch S, Partanen S, Suzuki K, Tyynela J, Thorne LB: Novel mutation and the first prenatal screening of cathepsin D deficiency (CLN10). Acta Neuropathol 2009, 117:201-208
16. Koike M, Nakanishi H, Saftig P, Ezaki J, Isahara K, Ohsawa Y, Schulz- Schaeffer W, Watanabe T, Waguri S, Kametaka S, Shibata M, Yamamoto K, Kominami E, Peters C, von Figura K, Uchiyama Y: Cathepsin D deficiency induces lysosomal storage with ceroid lipofuscin in mouse CNS neurons. J Neurosci 2000, 20:6898-6906
17. Koike M, Shibata M, Ohsawa Y, Nakanishi H, Koga T, Kametaka S, Waguri S, Momoi T, Kominami E, Peters C, Figura K, Saftig P, Uchiyama Y: Involvement of two different cell death pathways in retinal atrophy of cathepsin D-deficient mice. Mol Cell Neurosci 2003, 22:146-161
18. Yamasaki R, Zhang J, Koshiishi I, Sastradipura Suniarti DF, Wu Z, Peters C, Schwake M, Uchiyama Y, Kira J, Saftig P, Utsumi H, Nakanishi H: Involvement of lysosomal storage-induced p38 MAP kinase activation in the overproduction of nitric oxide by microglia in cathepsin D-deficient mice. Mol Cell Neurosci 2007, 35:573-584
19. Nakanishi H, Zhang J, Koike M, Nishioku T, Okamoto Y, Kominami E, von Figura K, Peters C, Yamamoto K, Saftig P, Uchiyama Y: Involvement of nitric oxide released from microglia-macrophages in pathological changes of cathepsin D-deficient mice. J Neurosci 2001, 21:7526-7533
20. Kügler S, Hahnewald R, Garrido M, Reiss J: Long-term rescue of a lethal inherited disease by adeno-associated virus-mediated gene transfer in a mouse model of molybdenum-cofactor deficiency. Am J Hum Genet 2007, 80:291-297 (Pubitemid 46175677)
21. Glondu M, Coopman P, Laurent-Matha V, Garcia M, Rochefort H, Liaudet-Coopman E: A mutated cathepsin-D devoid of its catalytic activity stimulates the growth of cancer cells. Oncogene 2001, 20:6920-6929 (Pubitemid 33052181)
22. Takahama Y: Journey through the thymus: stromal guides for T-cell development and selection. Nat Rev Immunol 2006, 6:127-135
23. Zakharov A, Papaiconomou C, Johnston M: Lymphatic vessels gain access to cerebrospinal fluid through unique association with olfactory nerves. Lymphat Res Biol 2004, 2:139-146 (Pubitemid 39600219)
24. Ni X, Canuel M, Morales CR: The sorting and trafficking of lysosomal proteins. Histol Histopathol 2006, 21:899-913
25. Tulone C, Uchiyama Y, Novelli M, Grosvenor N, Saftig P, Chain BM: Haematopoietic development and immunological function in the absence of cathepsin D. BMC Immunol 2007, 8:22 (Pubitemid 350048272)
26. Sondhi D, Peterson DA, Edelstein AM, del Fierro K, Hackett NR, Crystal RG: Survival advantage of neonatal CNS gene transfer for late infantile neuronal ceroid lipofuscinosis. Exp Neurol 2008, 213:18-27
27. Liu G, Martins I, Wemmie JA, Chiorini JA, Davidson BL: Functional correction of CNS phenotypes in a lysosomal storage disease model using adeno-associated virus type 4 vectors. J Neurosci 2005, 25:9321-9327 (Pubitemid 41464744)
28. Cashion MF, Banks WA, Bost KL, Kastin AJ: Transmission routes of HIV-1 gp120 from brain to lymphoid tissues. Brain Res 1999, 822:26-33
29. Dickstein JB, Moldofsky H, Lue FA, Hay JB: Intracerebroventricular injection of TNF-alpha promotes sleep and is recovered in cervical lymph. Am J Physiol 1999, 276:R1018-R1022
30. Cserr HF, Harling-Berg CJ, Knopf PM: Drainage of brain extracellular fluid into blood and deep cervical lymph and its immunological significance. Brain Pathol 1992, 2:269-276
31. Passini MA, Bu J, Fidler JA, Ziegler RJ, Foley JW, Dodge JC, Yang WW, Clarke J, Taksir TV, Griffiths DA, Zhao MA, O'Riordan CR, Schuchman EH, Shihabuddin LS, Cheng SH: Combination brain and systemic injections of AAV provide maximal functional and survival benefits in the Niemann-Pick mouse. Proc Natl Acad Sci USA 2007, 104:9505-9510
32. Fusek M and Vetvicka V: Dual role of cathepsin D: ligand and protease. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2005, 149:43-50
33. Laurent-Matha V, Lucas A, Huttler S, Sandhoff K, Garcia M, Rochefort H: Procathepsin D interacts with prosaposin in cancer cells but its internalization is not mediated by LDL receptor-related protein. Exp Cell Res 2002, 277:210-219 (Pubitemid 34757102)
34. Berchem G, Glondu M, Gleizes M, Brouillet JP, Vignon F, Garcia M, Liaudet-Coopman E: Cathepsin-D affects multiple tumor progression steps in vivo: proliferation, angiogenesis and apoptosis. Oncogene 2002, 21:5951-5955 (Pubitemid 35007248)
35. Beaujouin M, Baghdiguian S, Glondu-Lassis M, Berchem G, Liaudet-Coopman E: Overexpression of both catalytically active and -inactive cathepsin D by cancer cells enhances apoptosis-dependent chemosensitivity. Oncogene 2006, 25:1967-1973
36. Shevtsova Z, Malik JM, Michel U, Scholl U, Bähr M, Kügler S: Evaluation of epitope tags for protein detection after in vivo CNS gene transfer. Eur J Neurosci 2006, 23:1961-1969